Logo image
Defining and managing suicidal risk in patients taking psychotropic medications
Journal article   Peer reviewed

Defining and managing suicidal risk in patients taking psychotropic medications

Jan A Fawcett, Ross J Baldessarini, William H Coryell, Morton M Silverman and Dan J Stein
The journal of clinical psychiatry, Vol.70(6), pp.782-789
06/2009
DOI: 10.4088/JCP.8145co0c
PMID: 19573477

View Online

Abstract

In March 2004, the US Food and Drug Administration (FDA) issued a public health advisory warning that antidepressant treatment may increase suicidality and worsen depression in adult and pediatric patients. Then, in May 2007, the FDA proposed that the black box warning in the prescribing information for antidepressants and other drugs used to treat depression be updated to include a warning about an increased risk of suicidality in young adults. In January 2008, the FDA announced that antiepileptic medication labeling will be required to include a warning about an increased risk of suicidality
United States Humans Middle Aged Suicide - prevention & control Suicide, Attempted - statistics & numerical data Depressive Disorder - drug therapy Psychotropic Drugs - therapeutic use Psychotropic Drugs - adverse effects Young Adult Suicide - psychology Adult Odds Ratio Child United States Food and Drug Administration Cross-Sectional Studies Risk Assessment Treatment Outcome Hospitalization Suicide - statistics & numerical data Suicide, Attempted - prevention & control Antidepressive Agents - therapeutic use Suicide, Attempted - psychology Drug Labeling Mental Disorders - drug therapy Adolescent Aged Antidepressive Agents - adverse effects

Details

Metrics

Logo image